Filing Flows › Intelligent Bio Solutions (INBS) › Q4 FY25
Intelligent Bio Solutions (INBS) Q4 FY25 earnings results (fourth quarter fiscal 2025)
10-K filed Aug 15, 2025
Intelligent Bio Solutions (INBS) reported revenue of $844K for the fourth quarter fiscal 2025 (Q4 FY25), +16% from a year earlier and -6% from the quarter before. Operating margin was -368.1%, net loss $3.1M (367.7% of revenue).
Intelligent Bio Solutions, Q4 FY25: revenue $844K (+16% year over year), operating margin -368.1%, net loss $3.1M, operating cash flow −$2.2M. The chart follows the revenue to costs, profit and cash.
| Q4 FY25 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $844K | -6% | +16% |
| Operating profit | −$3.1M | — | — |
| Net earnings | −$3.1M | — | — |
| Operating cash flow | −$2.2M | — | — |
What changed
Revenue was $844K in Q4 FY25, up 16% year over year and down 6% from the previous quarter. Sales of Goods - Cartidges was the largest line at 57% of revenue.
Gross margin was 39.8%. Operating costs exceeded revenue by $3.1M, an operating margin of -368.1%. The quarter ended with a net loss of $3.1M, wider than the previous quarter's $2.6M loss. Minority interests bore $13K of it: to shareholders the quarter was a loss of $3.1M.
Operating cash flow was −$2.2M. Non-cash charges added back $244K of depreciation and amortization and $12K of share-based compensation. Working capital and other items added $637K.
Questions
What was Intelligent Bio Solutions' revenue in the fourth quarter fiscal 2025?
Intelligent Bio Solutions (INBS) reported revenue of $844K for the fourth quarter fiscal 2025 (Q4 FY25), +16% from a year earlier and -6% from the quarter before.
Was Intelligent Bio Solutions profitable in the fourth quarter fiscal 2025?
Operating loss was $3.1M (-368.1% of revenue) and net loss $3.1M.